Home Excelencia Severo Ochoa
Intercellular communication in the inflammatory response

Intercellular communication is fundamental to the innate and adaptive immune responses. Our group is interested in the molecular basis of key communication processes involving immune cells, such as the formation of the immune synapse between antigen presenting cells (APC) and T cells and the migration of leukocytes across the endothelium.

The immune synapse (IS) is a highly segregated structure formed at the contact site between the T cell and APC by the polarized reorganization of transmembrane and membraneassociated molecules. We are currently investigating the possibility that this structure permits the directional transfer of miRNA-loaded exosomes from T cell to APC, providing a specific means of cell-cell communication with important functional consequences for APC biology.

The interaction of leukocytes with the vascular endothelium is a highly regulated step-wise process that allows the selective recruitment of inflammatory leukocyte subsets to inflammatory foci, where they exert their effector functions. Understanding the supra-molecular organization of the receptors involved in this process is another of our main goals, with the ultimate aim of identifying new molecular targets for therapy. A related area of interest is the crucial roles played in inflammation by specific receptors: CD69, galectins, PSGL-1 and the tetraspanins CD9 and CD81. The biology of these molecules is being investigated using genedeficient mouse strains in models of diverse inflammatory diseases, including allergic asthma, experimental autoimmune myocarditis, delayed-contact hypersensitivity and DSS-induced ulcerative colitis.

We are also interested in T lymphocyte synthesis of nitric oxide (NO) and other soluble mediators that regulate the production of pro-inflammatory cytokines. Our interest here centers on the molecular mechanisms regulating polarized secretion during antigen-dependent T cell-APC interactions and the regulatory role of T-cell derived NO in vascular lesions.

Francisco Sánchez-Madrid
  • Francisco Sánchez Madrid
  • Group leader
  • Ext.2000

Education

 

School of Biological Sciences. Graduate and Licenciate in Biochemistry. 1972-1976.Universidad de Sevilla.

School of Biological Sciences. Universidad Autónoma de Madrid. 1977-1979.

Ph.D. in Biochemistry. 1980. Center for Molecular Biology “Severo Ochoa”.

 

Professional Experience

 

1977-1980. Fellow from Education and Science Spanish Ministry. Doctoral Thesis Ph. D. Work on function and biochemistry of ribosomal proteins. Centro de Biología Molecular. Universidad Autónoma de Madrid.

1980-1983. Postdoctoral Fellow from North-American Joint Committee for Science and Technology and from National Institute of Health (Fogarty Fundation). Structure and function of cell surface antigens involved in CTL-mediated cytotoxicity and leukocyte adhesion molecules. Research Fellow. Dept. Pathology. Dana-Farber Cancer Inst. Harvard Medical School. Boston, MA. USA. 

1984. Independent Investigator. Allergy and Immunology Institute of Abelló, S.A. Monoclonal antibodies to human immunoglobulins E and main allergen molecules from different sources.

1985-1989. Assistant Professor Dept. Immunology Hospital de la Princesa. Biochemical and functional characterization of cell surface glycoproteins associated to the activation process of human T cells. Leukocyte adhesion receptors.

1990- Professor of Immunology. Universidad Autónoma de Madrid. Dept. Immunology. Hospital de la Princesa. Functional role of leukocyte adhesion and activation receptors in inflammation. Cellular and molecular mechanisms regulating leukocyte polarity and migration, and their physiological relevance in inflammatory and autoimmune diseases.

 

Other appointments

 

Member Elected of EMBO. 1996.

Coordinator of Immunology and Infectious Diseases Section from FIS (Ministry of Health). 1998-2000.

Coordinator of BioMedicine National Program (Ministry Science and Technology). 2001-2005.

ERC Panel Member (2007-2010)